COVID-19 and Mucormycosis Coinfection: How Challenging It Is
Recently, cases of rhinoorbital mucormycosis in people diagnosed with COVID-19 have been reported from India particularly. Diabetes mellitus though happens to be an independent risk factor both for severe COVID-19 and mucormycosis, administration of steroids is attributed as a precipitating factor f...
Saved in:
Main Authors: | Niranjan Nayak, Erum Khan, Debadatta Panigrahi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Canadian Journal of Infectious Diseases and Medical Microbiology |
Online Access: | http://dx.doi.org/10.1155/2022/8617212 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cutaneous Mucormycosis Co-infection in a Patient with COVID-19
by: Raham Rahgoshai, et al.
Published: (2022-10-01) -
Mathematical Modeling and Analysis of TB and COVID-19 Coinfection
by: Kassahun Getnet Mekonen, et al.
Published: (2022-01-01) -
Rhino-Orbital-Cerebral Mucormycosis in a Post-COVID-19 Patient from Peru
by: Linda Ponce-Rosas, et al.
Published: (2022-01-01) -
Analysis of Turberculosis-COVID-19 Coinfection Using Fractional Derivatives
by: Samuel Okyere, et al.
Published: (2023-01-01) -
Streptococcus pneumoniae Coinfection in COVID-19: A Series of Three Cases
by: Chaitanya Pal, et al.
Published: (2020-01-01)